| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 710716 | Null | 0.0282295482823988 | -0.0020568782 |
| NSC 716032 | Null | 0.0282295482823988 | 0.14888182 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0282295482823988 | 0.2786381 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0282295482823988 | 0.10755729 |
| NSC 736041 | 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne | 0.0282295482823988 | 0.14239563 |
| NSC 740 | Methotrexate | 0.0282295482823988 | 0.30467259 |
| NSC 335791 | 3-Azabicyclo[3.2.2]nonane-3-carbothioic acid, [1-(2-pyridinyl)butylidene]hydrazide | 0.0354402685381449 | 0.22961956 |
| NSC 622700 | Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide | 0.0354402685381449 | 0.069941186 |
| NSC 630684 | 8-Quinolinecarboxaldehyde, 2-(2,4-dinitrophenyl)-2-methyl- hydrazone | 0.0354402685381449 | 0.055229697 |
| NSC 675006 | Null | 0.0354402685381449 | 0.36463162 |